387 related articles for article (PubMed ID: 25773885)
1. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.
Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Österborg A; Lundqvist A
Eur J Immunol; 2015 Jun; 45(6):1783-93. PubMed ID: 25773885
[TBL] [Abstract][Full Text] [Related]
2. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
[TBL] [Abstract][Full Text] [Related]
3. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
4. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
Wehner R; Löbel B; Bornhäuser M; Schäkel K; Cartellieri M; Bachmann M; Rieber EP; Schmitz M
Int J Cancer; 2009 Jan; 124(2):358-66. PubMed ID: 18942710
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells: the secret weapon in dendritic cell vaccination strategies.
Van Elssen CH; Oth T; Germeraad WT; Bos GM; Vanderlocht J
Clin Cancer Res; 2014 Mar; 20(5):1095-103. PubMed ID: 24590885
[TBL] [Abstract][Full Text] [Related]
7. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.
Wong JL; Mailliard RB; Moschos SJ; Edington H; Lotze MT; Kirkwood JM; Kalinski P
J Immunother; 2011 Apr; 34(3):270-8. PubMed ID: 21389871
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.
Hunter CA; Bermudez L; Beernink H; Waegell W; Remington JS
Eur J Immunol; 1995 Apr; 25(4):994-1000. PubMed ID: 7737303
[TBL] [Abstract][Full Text] [Related]
9. Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine.
Gustafsson K; Ingelsten M; Bergqvist L; Nyström J; Andersson B; Karlsson-Parra A
Cancer Res; 2008 Jul; 68(14):5965-71. PubMed ID: 18632652
[TBL] [Abstract][Full Text] [Related]
10. Regulatory Dendritic Cells Restrain NK Cell IFN-γ Production through Mechanisms Involving NKp46, IL-10, and MHC Class I-Specific Inhibitory Receptors.
Spallanzani RG; Torres NI; Avila DE; Ziblat A; Iraolagoitia XL; Rossi LE; Domaica CI; Fuertes MB; Rabinovich GA; Zwirner NW
J Immunol; 2015 Sep; 195(5):2141-8. PubMed ID: 26232426
[TBL] [Abstract][Full Text] [Related]
11. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
12. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
[TBL] [Abstract][Full Text] [Related]
13. PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta.
Duluc D; Tan F; Scotet M; Blanchard S; Frémaux I; Garo E; Horvat B; Eid P; Delneste Y; Jeannin P
Eur J Immunol; 2009 Oct; 39(10):2877-84. PubMed ID: 19728309
[TBL] [Abstract][Full Text] [Related]
14. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii.
Hunter CA; Ellis-Neyer L; Gabriel KE; Kennedy MK; Grabstein KH; Linsley PS; Remington JS
J Immunol; 1997 Mar; 158(5):2285-93. PubMed ID: 9036976
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal activating interaction between natural killer cells and dendritic cells.
Gerosa F; Baldani-Guerra B; Nisii C; Marchesini V; Carra G; Trinchieri G
J Exp Med; 2002 Feb; 195(3):327-33. PubMed ID: 11828007
[TBL] [Abstract][Full Text] [Related]
16. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
[TBL] [Abstract][Full Text] [Related]
17. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells.
Gruenbacher G; Gander H; Nussbaumer O; Nussbaumer W; Rahm A; Thurnher M
Cancer Res; 2010 Dec; 70(23):9611-20. PubMed ID: 20947520
[TBL] [Abstract][Full Text] [Related]
18. Regulation of NK cell functions by TGF-beta 1.
Bellone G; Aste-Amezaga M; Trinchieri G; Rodeck U
J Immunol; 1995 Aug; 155(3):1066-73. PubMed ID: 7636180
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities.
Jinushi M; Takehara T; Tatsumi T; Yamaguchi S; Sakamori R; Hiramatsu N; Kanto T; Ohkawa K; Hayashi N
Immunology; 2007 Jan; 120(1):73-82. PubMed ID: 17052247
[TBL] [Abstract][Full Text] [Related]
20. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Kanto T; Tatsumi T; Groh V; Spies T; Miyagi T; Suzuki T; Sasaki Y; Hayashi N
J Immunol; 2003 Feb; 170(3):1249-56. PubMed ID: 12538683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]